glp-1 drug news today 2025 shortages november weight loss Weight-Loss Drugs Could Address a Range of Addictions GLP-1 Trends: Access & Shortages, – FDA takes aim at telehealth – ISPOR 2025: Exploring reasons for

Reported side effects are infrequent and mild: Mild headache or dizziness following administration

suggested that ARA-290 peptide may attenuate age-associated decline in cardiac function in laboratory models, while also potentially reducing systemic inflammation and preserving late-life body weight in aged rat laboratory models

Muscle Recovery

The Future of GLP-1s in Mental Health Treatment While more research is needed, early findings point to GLP-1s as promising tools in the treatment of addiction, depression, and neurodegenerative diseases

Less common Persistent small lumps beyond a week rare with surgeon technique

doi: 10.1007/BF01538078 24 HolstJJSorensenTIAndersenANStadilFAndersenBLauritsenKBet al